Literature DB >> 21118969

Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.

Ramune Reliene1, Mitsuko L Yamamoto, P Nagesh Rao, Robert H Schiestl.   

Abstract

Fanconi anemia (FA) results from mutations in the FANC genes and is characterized by bone marrow failure, birth defects, and a high incidence of cancer. FANCG is a part of the FA core complex that is responsible for monoubiquitination of FANCD2 and FANCI. The precise role of the FA pathway is not well understood, although it may be involved in homologous recombination (HR), nonhomologous end joining, and translesion synthesis (TLS). Fancd2(-/-) mice have a more severe phenotype than Fancg(-/-), and other FA core complex-deficient mice, although both Fancg and Fancd2 belong to the same FA pathway. We hypothesized that Fancd2 deficiency results in a more severe phenotype because Fancd2 also has a FA pathway-independent function in the maintenance of genomic integrity. To test this hypothesis, we determined the level of DNA damage and genomic instability in Fancd2(-/-), Fancg(-/-), and wild-type controls. Fancd2(-/-) mice displayed a higher magnitude of chromosomal breakage and micronucleus formation than the wild-type or Fancg(-/-) mice. Also, DNA strand breaks were increased in Fancd2(-/-) but not in Fancg(-/-) mice. In addition, Fancd2(-/-) mice displayed an elevated frequency of DNA deletions, resulting from HR at the endogenous p(un) locus. In contrast, in Fancg(-/-) mice, the frequency of DNA deletions was decreased. Thus, Fancd2 but not Fancg deficiency results in elevated chromosomal/DNA breakage and permanent genome rearrangements. This provides evidence that Fancd2 plays an additional role in the maintenance of genomic stability than Fancg, which might explain the higher predisposition to cancer seen in the Fancd2(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118969      PMCID: PMC3059244          DOI: 10.1158/0008-5472.CAN-09-1022

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  Fanconi anemia (cross)linked to DNA repair.

Authors:  Laura J Niedernhofer; Astrid S Lalai; Jan H J Hoeijmakers
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 2.  Involvement of homologous recombination in carcinogenesis.

Authors:  Ramune Reliene; Alexander J R Bishop; Robert H Schiestl
Journal:  Adv Genet       Date:  2007       Impact factor: 1.944

3.  Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.

Authors:  Alberto Ciccia; Chen Ling; Rachel Coulthard; Zhijiang Yan; Yutong Xue; Amom Ruhikanta Meetei; El Houari Laghmani; Hans Joenje; Neil McDonald; Johan P de Winter; Weidong Wang; Stephen C West
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

4.  FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.

Authors:  Chen Ling; Masamichi Ishiai; Abdullah Mahmood Ali; Annette L Medhurst; Kornelia Neveling; Reinhard Kalb; Zhijiang Yan; Yutong Xue; Anneke B Oostra; Arleen D Auerbach; Maureen E Hoatlin; Detlev Schindler; Hans Joenje; Johan P de Winter; Minoru Takata; Amom Ruhikanta Meetei; Weidong Wang
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

5.  A requirement of FancL and FancD2 monoubiquitination in DNA repair.

Authors:  Sohsuke Seki; Mioko Ohzeki; Akiko Uchida; Seiki Hirano; Nobuko Matsushita; Hiroyuki Kitao; Tsukasa Oda; Takayuki Yamashita; Naoki Kashihara; Akio Tsubahara; Minoru Takata; Masamichi Ishiai
Journal:  Genes Cells       Date:  2007-03       Impact factor: 1.891

Review 6.  Molecular pathogenesis of Fanconi anemia: recent progress.

Authors:  Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

7.  The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly.

Authors:  Kanchan D Mirchandani; Ryan M McCaffrey; Alan D D'Andrea
Journal:  DNA Repair (Amst)       Date:  2008-04-29

8.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

Authors:  Sarah Reid; Detlev Schindler; Helmut Hanenberg; Karen Barker; Sandra Hanks; Reinhard Kalb; Kornelia Neveling; Patrick Kelly; Sheila Seal; Marcel Freund; Melanie Wurm; Sat Dev Batish; Francis P Lach; Sevgi Yetgin; Heidemarie Neitzel; Hany Ariffin; Marc Tischkowitz; Christopher G Mathew; Arleen D Auerbach; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.

Authors:  Agata Smogorzewska; Shuhei Matsuoka; Patrizia Vinciguerra; E Robert McDonald; Kristen E Hurov; Ji Luo; Bryan A Ballif; Steven P Gygi; Kay Hofmann; Alan D D'Andrea; Stephen J Elledge
Journal:  Cell       Date:  2007-04-05       Impact factor: 41.582

10.  Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis.

Authors:  John M Hinz; Peter B Nham; Salustra S Urbin; Irene M Jones; Larry H Thompson
Journal:  Nucleic Acids Res       Date:  2007-05-21       Impact factor: 16.971

View more
  8 in total

1.  The impact of FANCD2 deficiency on formaldehyde-induced toxicity in human lymphoblastoid cell lines.

Authors:  Xuefeng Ren; Zhiying Ji; Cliona M McHale; Jessica Yuh; Jessica Bersonda; Maycky Tang; Martyn T Smith; Luoping Zhang
Journal:  Arch Toxicol       Date:  2012-08-08       Impact factor: 5.153

2.  Gene expression profiling to identify the toxicities and potentially relevant disease outcomes due to endosulfan exposure.

Authors:  Dan Xu; Shuai Li; Limei Lin; Fei Qi; Xiaoming Hang; Yeqing Sun
Journal:  Toxicol Res (Camb)       Date:  2016-01-22       Impact factor: 3.524

3.  A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.

Authors:  X Chen; L Bosques; P Sung; G M Kupfer
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

4.  Differential effects of silver nanoparticles on DNA damage and DNA repair gene expression in Ogg1-deficient and wild type mice.

Authors:  Sameera Nallanthighal; Cadia Chan; Thomas M Murray; Aaron P Mosier; Nathaniel C Cady; Ramune Reliene
Journal:  Nanotoxicology       Date:  2017-10-19       Impact factor: 5.913

5.  Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer.

Authors:  Amin El-Heliebi; Karl Kashofer; Julia Fuchs; Stephan W Jahn; Christian Viertler; Andrija Matak; Peter Sedlmayr; Gerald Hoefler
Journal:  Histochem Cell Biol       Date:  2017-03-20       Impact factor: 4.304

6.  Mouse Lymphoblastic Leukemias Induced by Aberrant Prdm14 Expression Demonstrate Widespread Copy Number Alterations Also Found in Human ALL.

Authors:  Stephen J Simko; Horatiu Voicu; Brandi L Carofino; Monica J Justice
Journal:  Cancers (Basel)       Date:  2012-10-18       Impact factor: 6.639

Review 7.  Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models.

Authors:  Sietske T Bakker; Johan P de Winter; Hein te Riele
Journal:  Dis Model Mech       Date:  2013-01       Impact factor: 5.758

8.  Primary Ovarian Insufficiency Induced by Fanconi Anemia E Mutation in a Mouse Model.

Authors:  Chun Fu; Khurshida Begum; Paul A Overbeek
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.